Evidence map›Paper›PMID 12456783›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2002

Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.

José L Crespo, Michael N Hall

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 167 papers.

0numbers the graph read from it
0cells of the map it votes in
167citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

167 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Microbiology spectrum · 2023
    Article
  16. Review
  17. Article
  18. Interactions between antifungals and everolimus againstFrontiers in cellular and infection microbiology · 2023
    Article
  19. Target of Rapamycin Regulates Photosynthesis and Cell Growth inInternational journal of molecular sciences · 2022
    Article
  20. Article

107 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

José L CrespoDivision of Biochemistry, Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
Michael N Hall

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TOR (target of rapamycin) is a phosphatidylinositol kinase-related protein kinase that controls cell growth in response to nutrients. Rapamycin is an immunosuppressive and anticancer drug that acts by inhibiting TOR. The modes of action of TOR and rapamycin are remarkably conserved from S. cerevisiae to humans. The current understanding of TOR and rapamycin is derived largely from studies with S. cerevisiae. In this review, we discuss the contributions made by S. cerevisiae to understanding rapamycin action and TOR function.

Indexed as

Phosphatidylinositol 3-KinasesSaccharomyces cerevisiae ProteinsAnimalsAntifungal AgentsCell Cycle ProteinsFungal ProteinsHumansImmunosuppressive AgentsPhosphotransferases (Alcohol Group Acceptor)RibosomesSaccharomyces cerevisiaeSignal TransductionSirolimusTacrolimus Binding Protein 1AAntifungal AgentsCell Cycle ProteinsFungal ProteinsImmunosuppressive AgentsPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Saccharomyces cerevisiae ProteinsSirolimusTacrolimus Binding Protein 1ATOR1 protein, S cerevisiaeTOR2 protein, S cerevisiae

Identifiers

PMID12456783
PMCPMC134654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.